Steris (STE) Short-Term Debt issuances (2018 - 2026)
Steris (STE) posted quarterly Short-Term Debt issuances of $37.8 million for Q1 2026, up 129.69% year-over-year from $16.5 million in Q1 2025, and up 979.07% quarter-over-quarter from -$4.3 million in Q3 2025.
Steris (STE) Short-Term Debt issuances (2018 - 2026) Analysis & Trends
Steris' Short-Term Debt issuances history runs 9 years deep, the most recent figure standing at $37.8 million for Q1 2026.
- In Q1 2026, Short-Term Debt issuances rose 129.69% year-over-year to $37.8 million; the TTM figure through Mar 2026 stood at $3.0 million (up 100.67% YoY), while the FY2026 annual figure was $3.0 million, up 100.67% from the prior year.
- Short-Term Debt issuances for Q1 2026 stood at $37.8 million, up from -$4.3 million in the prior quarter.
- The five-year high for Short-Term Debt issuances was $535.7 million in Q3 2023, with the low at -$253.2 million in Q2 2024.
- The 5-year median for Short-Term Debt issuances is $4.7 million (2022), against an average of -$407000.0.
- Peak annual rise in Short-Term Debt issuances reached 762.6% in 2023, while the deepest fall reached 490.83% in 2023.
- Steris' Short-Term Debt issuances stood at $117.4 million in 2022, then plunged by 206.87% to -$125.5 million in 2023, then soared by 120.63% to $25.9 million in 2024, then slumped by 116.6% to -$4.3 million in 2025, then surged by 979.07% to $37.8 million in 2026.
- Business Quant data shows STE's Short-Term Debt issuances at $37.8 million in Q1 2026, -$4.3 million in Q3 2025, and -$30.5 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Short-Term Debt issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 64.00 Mn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | - |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | -164.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 1.42 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | - |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -47.66 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | -37.80 Mn |
| 10 | Zimmer Biomet Holdings | 19.42 Bn | 19.01 Bn | 1.54 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -37.80 Mn |
| Jun 30, 2026 | -37.80 Mn |
| Mar 31, 2026 | 37.80 Mn |
| Mar 31, 2026 | 37.80 Mn |
| Sep 30, 2025 | -4.30 Mn |
| Sep 30, 2025 | -4.30 Mn |
| Jun 30, 2025 | -30.50 Mn |
| Jun 30, 2025 | -30.50 Mn |
| Mar 31, 2025 | -127.30 Mn |
| Mar 31, 2025 | -127.30 Mn |
| Dec 31, 2024 | 25.90 Mn |
| Dec 31, 2024 | 25.90 Mn |
| Sep 30, 2024 | -91.70 Mn |
| Sep 30, 2024 | -91.70 Mn |
| Jun 30, 2024 | -253.20 Mn |
| Jun 30, 2024 | -253.20 Mn |
| Mar 31, 2024 | -84.00 Mn |
| Mar 31, 2024 | -84.00 Mn |
| Dec 31, 2023 | -125.52 Mn |
| Dec 31, 2023 | -125.52 Mn |